Global /South Korea /Healthcare /Medical Devices /096530
chevron_leftBack
Seegene, Inc. logo

Seegene, Inc.

096530
KRX: 096530 Delayed
24,550KRW -2%
16.02 USD
As of 6 June 2026, Seegene, Inc. has a market cap of $753.63M USD, ranking #12451 globally and #344 in South Korea. It ranks #1141 in the Healthcare sector, and #228 in the Medical Devices industry.
Global Rank
12451
Country Rank
344
Sector Rank
1141
Industry Rank
228
Key Stats
Market Cap
$753.63MUSD
1.16T KRW
Enterprise Value
$456.39MUSD
699.57B KRW
Revenue (TTM)
$309.39MUSD
474.23B KRW
EBITDA (TTM)
$68.21MUSD
104.56B KRW
Net Income (TTM)
$31.49MUSD
48.27B KRW
EBITDA Margin
22%
Profit Margin
10%
PE Ratio
23.9
Forward PE
29.5
PS Ratio
2.4
PB Ratio
1.1
EV/EBITDA
6.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Jong-Yoon Chun open_in_new
Employees
216
Founded
2000
Website
seegene.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2% 0.8% 7.3% -8.9% -5.5% -5.5%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
096530
(주)씨젠
ISIN: KR7096530001
Shares Out.:
45.556M1 Shares Float: 26.551M2
TV:
SA:
YF:
GF:
BA:
MS:
24,550 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Seegene, Inc.

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)
Name
Market Cap diff.
PE
214150
$2.45B
3.75T KRW
225%
28.7
458870
$1.22B
1.86T KRW
61%
114.8
491000
$1.18B
1.81T KRW
57%
-
290650
$1.13B
1.74T KRW
50%
-
214430
$528.2M
809.64B KRW
-30%
83.3
199800
$522.65M
801.13B KRW
-31%
-
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
23K%
25.8
$160.73B
21K%
56.7
$159.07B
21K%
25.6
DHR
$126.55B
17K%
34.7
SYK
$120.69B
16K%
38.3
MDT
$101.9B
13K%
22.2
chevron_leftBack